Related Experiment Video
Updated: May 24, 2026
06:45
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism
Gaëtan Garraux1, Jean-Hubert Caberg, Jean-François Vanbellinghen
1MOVERE Group, Department of Neurology, University Hospital Center of Liège, and Cyclotron Research Center, University of Liège, Belgium. ggarraux@ulg.ac.be
Archives of Neurology
|March 14, 2012
Summary
A rare genetic duplication on chromosome 4q caused young-onset parkinsonism in a 31-year-old woman. This finding offers new insights into the genetic causes of parkinsonism.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Parkinsonism is a complex neurological disorder.
- Genetic factors play a role in early-onset parkinsonism.
- De novo genetic mutations are increasingly recognized causes of neurological disorders.
Observation:
- A case report details a 31-year-old woman with young-onset, dopa-responsive parkinsonism.
- Genetic analysis revealed a de novo heterozygous interstitial duplication on chromosome 4q.
- The duplication encompasses the alpha-synuclein (SNCA) gene locus.
Findings:
- The patient's motor and imaging features resemble those of known SNCA duplication carriers.
- The duplication may influence other genes, contributing to atypical symptoms like developmental delays and musculoskeletal issues.
- This case highlights the phenotypic variability associated with chromosome 4q duplications.
Implications:
- This case expands the understanding of genetic underpinnings of parkinsonism.
- It suggests that broader genetic analyses are crucial for diagnosing atypical parkinsonian syndromes.
- Further research into the role of genes within the 4q duplication is warranted to elucidate their contribution to neurological phenotypes.
Related Concept Videos
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...